Emovi

Montreal, Canada Founded: 2007 • Age: 19 yrs
Developer of a knee assessment device

About Emovi

Emovi is a company based in Montreal (Canada) founded in 2007. Emovi has raised $11.27 million across 2 funding rounds from investors including Desjardins, Stand Up Ventures and TVM Capital Life Science. Emovi offers products and services including KneeKG System. Emovi operates in a competitive market with competitors including Theranica, Sooma Oy, Bone Health Technologies, Mainstay Medical and Imagen, among others.

  • Headquarter Montreal, Canada
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website emovi.ca
  • Social LinkedIn X Facebook Instagram YouTube
Key Metrics
  • Total Equity Funding
    $11.27M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.76M (USD), Debt – Conventional

    Mar 2019

  • Investors
    Desjardins

    & 2 more

Products & Services of Emovi

Emovi offers a comprehensive portfolio of products and services, including KneeKG System.

KneeKG System
Medical Device

AI tool for measuring 3D knee alignment to enhance orthopaedic diagnostics

Apps and channels of Emovi

its YouTube channel Emovi KneeKG has 541 subscribers and 4 videos.

Emovi KneeKG
YouTube 541 subscribers 4 videos Science & Technology
Open channel

Videos from Emovi

The most watched videos on Emovi's YouTube channel, Emovi KneeKG (541 subscribers). Click a video to play it here.

La santé des genoux, c'est pour tout le monde!
271K views
La santé des genoux, c'est pour tout le monde
128K views
Knee Kinesiography Overview
84 views
Genougraphie aperçu
35 views

More on Emovi KneeKG.

Funding Insights of Emovi

Emovi has successfully raised a total of $11.27M across 2 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3.76 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $11.27M
  • Total Rounds 2
  • Last Round Debt – Conventional — $3.76M
  • First Round $11.27M

    (Mar 2019)

  • Investors Count 3

All 2 funding rounds of Emovi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2019$11.27MSeries C–TVM Capital
Mar 2019$3.76MDebt – Conventional––
–
Valuation history

3 investors in total: 3 institutional.

Investors in Emovi

Emovi has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Desjardins, Stand Up Ventures and TVM Capital Life Science.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Seed-stage investments are made in women-led technology companies.
–standupvc.comToronto, Canada
Capital is invested in life science innovations for healthcare transformation.
–tvm-capital.comMunich, Germany
Financial services are provided cooperatively to members in Canada.
1900desjardins.comLevis, Canada
Premium access

Investor details for Emovi

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Emovi

10 people are tracked at Emovi (3 in leadership, 7 in team).

NameRoleGroup
Michelle Laflamme
CEO & PresidentLeadership
Alexandre Fuentes
Chief Scientific and Technology Officer, CSO & CTOLeadership
Valerie Girand Wilson
Vice President of Operations, Implementation and EducationLeadership
Alix CAGNIN
R&D Project ManagerTeam
Sam Guirguis
Software Project ManagerTeam
Bianca Marois
R&d Project ManagerTeam
Véronica Rabanal-Duchesne
Chargée De Projet R DTeam
Lisa Herbert
Medical Education CommunicationTeam
Lorne Beckman
Implementation LeadTeam
Lise Lheureux
Responsable Formation - Support Aux PatientsTeam
Premium access

Complete people profiles for Emovi

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Emovi

2 dated milestones of Emovi across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Emovi is founded.
  2. Funding First funding round of $11.3M.

Competitors of Emovi

Emovi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Theranica, Sooma Oy, Bone Health Technologies, Mainstay Medical and Imagen, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
theranica.com2016Bridgewater, United States$86M–
Therapeutic devices for pain management are developed and manufactured.
soomamedical.com2013Helsinki, Finland$6.58M–
Non-invasive neuromodulation therapies
bonehealthtech.com2018San Francisco, United States––
Bone Health Technologies creates a wearable device to treat osteopenia and prevent osteoporosis.
mainstaymedical.com2008Dublin, Ireland$27.2M–
Provider of rehabilitation solutions for patients and doctors
imagen.ai2016New York, United States$59.69M–
AI solutions for detecting pathologies in medical images are developed.
sprtherapeutics.com2010Cleveland, United States––
Pioneers non-invasive devices for chronic pain relief through medical innovation.
zetroz.com2009Trumbull, United States$6.78M10
Wearable bioelectronic devices for acoustic medicine treatments are developed.
profusa.com2009San Francisco, United States$64.92M15
Biochemical sensors are developed for real-time chronic disease monitoring.
medasense.com2008Ramat Gan, Israel$26M–
Non-invasive pain-monitoring devices are developed for clinical settings.
Premium access

Detailed competitors of Emovi

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Emovi

Premium access

Complete news archive for Emovi

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Emovi

10 companies that operate in the same segment as Emovi (Orthopedics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Prosthetic and orthotic devices are developed for individuals with disabilities.
1919Duderstadt, Lower Saxony, GermanyUSD 17 MUSD 1.97 B–
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Developer of drugs for treating rare and autoimmune diseases
2008Dublin, IrelandUSD 61.78 MUSD 617.41 M–
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Smart surgical devices for spinal surgery are developed.
1997San Diego, California, United StatesUSD 54.1 M––
Robotic arms are provided for mobility and rehabilitation support.
2004Boston, Massachusetts, United StatesUSD 17.21 MUSD 40.93 M185
AI-powered drug discovery platform for various diseases
2016New York, New York, United StatesUSD 608 M––
Exoskeletons for medical rehabilitation and industrial productivity are provided.
2005United StatesUSD 24.37 MUSD 71.6 M61
Stabilization devices for healthcare are manufactured by the company.
2005New York, New York, United StatesUSD 142.15 M–43
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Emovi

Emovi was founded in 2007 and raised its 1st funding round 12 years after it was founded.

Emovi is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.

Michelle Laflamme is the current CEO of Emovi.

Emovi is a funded company, having raised a total of $11.27M across 2 funding rounds to date. The company's 1st funding round was a Series C of $11.27M, raised on Mar 2019.

Emovi was founded in 2007 in Montreal, Canada, within the medical device sector. The KneeKG system is utilized to gather data on knee joint kinematics, biochemical markers, gait patterns, and underlying pain sources. Insights derived from this information support the delivery of targeted, evidence-based therapies. Operations focus on advancing knee health diagnostics through technology integration in clinical settings.

Emovi's top competitors include Theranica, Mainstay Medical and Profusa.

Emovi offers KneeKG System.

Emovi has 3 investors. Key investors include Desjardins, Stand Up Ventures, and TVM Capital Life Science.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available